Caricamento...
Temozolomide in the era of precision medicine
In this issue of Cancer Research, Nagel and colleagues demonstrate the value of assays that determine the DNA repair capacity of cancers in predicting response to temozolomide. Using a fluorescence-based multiplex flow-cytometric host cell reactivation (FM-HCR) assay that provides simultaneous reado...
Salvato in:
Pubblicato in: | Cancer Res |
---|---|
Autori principali: | , , , , , |
Natura: | Artigo |
Lingua: | Inglês |
Pubblicazione: |
2017
|
Soggetti: | |
Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5313339/ https://ncbi.nlm.nih.gov/pubmed/28159862 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-16-2983 |
Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|